To identify genes which overexpression results into chromosomal instability (CIN), we developed a biological approach based on a yeast indicator strain in which CIN can be detected by a sectoring phenotype. Screening in this strain of a yeast genomic library cloned into a high copy vector led us to identify, among the clones generating 100% of sectoring colonies, Clb5, one of the six B-type cyclins present in yeast. Overexpression of cyclin B2 and cyclin B1, the two human homologs of Clb5, in the CIN indicator strain resulted also into a sectoring phenotype and induced, like overexpression of Clb5, an abnormal sensitivity to benomyl, indicating that overexpression of B-type cyclins alters the spindle checkpoint. In a series of 38 primary colorectal cancers, we detected in ®ve tumors (13%) an accumulation of cyclin B1, which was neither related to mRNA overexpression nor to mutation within the coding region, and in ®ve other tumors (13%) a 2 ± 10-fold increase of cyclin B2 mRNA which was not related to gene ampli®cation. These results suggest that overexpression of cyclins B, resulting from dierent mechanisms, could contribute, through an alteration of the spindle checkpoint, to the chromosomal instability observed in cancer.
Introduction
Genetic instability is the hallmark of cancer, and two types of instability have been clearly recognized so far (Lengauer et al., 1997 . Whereas microsatellite instability (MIN) has been shown to result from the alteration of the mismatch repair genes (MMR), the molecular basis of chromosomal instability (CIN) remains to be characterized. Identi®cation of genes involved in CIN represents an important challenge with potential therapeutic applications, since CIN is observed in most of the cancers and is speci®c of the malignant transformation. Cancerous cells exhibiting CIN have been shown to be defective in the spindle checkpoint (Cahill et al., 1998) . This checkpoint, which is essential for a proper chromosomal segregation, controls separation of sister chromatids during the metaphase/anaphase transition (for review see Amon, 1999) . In yeast and vertebrates, the separation of sister chromatids results from the cleavage of cohesin's subunit SCC1 by the protease separin (Hauf et al., 2001) . Before anaphase, separins are complexed to securins and induction of anaphase requires the degradation of securins by the proteolytic complex APC (Anaphase Promoting Complex), an ubiquitin ligase, which ubiquinates regulators of sister chromatids separation. During mitosis, sister chromatids normally attach to the spindle microtubules of the spindle via a DNA-protein complex, the centromere or kinetochore. A defect in the kinetochore attachment to the spindle, or an alteration of the spindle itself, will activate proteins localized within the kinetochore such as BUB (Budding Uninhibited by Benomyl) 1, 2, 3 and MAD (Mitotic Arrest Defect) 1, 2, 3 and the activation of these proteins will inhibit APC. Therefore, alteration of the genes involved in the spindle checkpoint may result in an abnormal chromosome segregation and this was initially demonstrated by the identi®cation of somatic BUB1 mutations in aneuploid colorectal tumors (Cahill et al., 1998) . The human homolog of the yeast securin, which corresponds to the PTTG (pituitary tumor-transforming gene) gene (Zou et al., 1999) has been shown to be overexpressed in colorectal cancers (Heaney et al., 2000) . Mutations of MAD1L1, the human homolog of yeast gene MAD1, have been documented in cell lines and primary tumors (Cahill et al., 1999; Tsukasaki et al., 2001) . The MAD2 gene also appears to be an excellent candidate for CIN, since haplo-insuciency of MAD2, experimentally induced by homologous recombination, results into CIN in mammalian cells (Michel et al., 2001) . Inactivation of the Adenomatous Polyposis Coli (APC) tumor suppressor gene, which is a key event in colorectal carcinogenesis, might be itself involved in CIN, since inactivation in mice of the APC protein, which is located at the ends of the spindle attached to the kinetochore, alters chromosome segregation (Fodde et al., 2001; Kaplan et al., 2001) .
To identify other genes involved in CIN, we developed a functional screening in Saccharomyces cerevisiae based on the colony color sectoring assay developed by Koshland and Hieter (1987) . This assay uses a strain in which the ade2-mutation, resulting into the accumulation of a red pigment, has been suppressed by an ochre suppressing tRNA SUP 11, carried by a non essential arti®cial chromosomal fragment. In this strain, which is spontaneously white on media containing a limiting amount of adenine, induction of CIN will result, during mitosis, into the loss of the chromosomal fragment and therefore into the appearance of red sectors within white colonies. This sectoring phenotype therefore represents a simple visual test for CIN. We screened in this indicator strain a yeast genomic library cloned in a high copy vector to identify genes which overexpression results into CIN.
Results

Overexpression of the B-type cyclin Clb5 alters chromosomal segregation in yeast
The 2 mm plasmid, in which the yeast genomic library was cloned, replicates at 60 copies per cell mimicking therefore the gene ampli®cation observed in cancer cells. Approximately 10 000 colonies, corresponding to three yeast genome equivalents, were screened into the YPH1015 CIN indicator strain for the sectoring phenotype. Plasmids were rescued from sectoring colonies, and the dierent corresponding ORF(s) were sub-cloned, in the CIN indicator strain YPH1015, by homologous recombination into the pMET25-URA vector, containing the MET25 promoter which is repressed when cells are grown in the presence of methionine. One of the ORFs, generating 100% sectoring colonies on solid media without methionine, corresponded to Clb5, one of the six B-type cyclins identi®ed in yeast. Cells transformed with pMET-Clb5 were highly sectored ( Figure  1 ), indicating that overexpression of Clb5 dramatically increased chromosome loss. Cells DNA content analysis performed by FACS showed that Clb5 overexpression in yeast induced the appearance of an extra peak (Figure 2 ), con®rming that Clb5 overexpression is sucient to induce aneuploidy in yeast.
Overexpression of Clb5 alters the spindle checkpoint
To analyse the eect of Clb5 overexpression in yeast on the spindle checkpoint, yeast cells were treated with benomyl which depolymerizes the spindle microtubules. In normal cells, activation of the spindle checkpoint allows the cells to repair the lesions and results into a resistance to the drug (Figure 3 ). In contrast, cells transformed with the pMET-Clb5 vector, exhibited (Figure 3 ), such as a strain deleted for BUB1, used as a positive control (Figure 3 ), an abnormal sensitivity to the drug, demonstrating that Clb5 overexpression alters the spindle checkpoint.
Overexpression of human cyclins B alters chromosomal segregation and the spindle checkpoint in yeast B-type cyclins are highly conserved along evolution and two B-type cyclins have been identi®ed in human. Clb5 displays 45% of similarity and 24% of identity with human cyclin B2 and 44% of similarity and 26% of identity with human cyclin B1 (Figure 4 ). Human cyclin B1 and B2 cDNAs were cloned by homologous recombination into the pMET25-URA vector in the CIN indicator strain. Overexpression of cyclin B2 induced the appearance of red sectors (Figure 1 ), although the eect was weaker than that obtained with Clb5 (the number of red sectors per colony was lower), probably because of the heterolog expression of a human gene in yeast.
Cloning by homologous recombination of the human cyclin B1 cDNA into the pMET25-URA vector resulted into few colonies which had all a sectoring phenotype (Figure 1 ), but sequencing analysis of plasmids rescued from these colonies revealed that all the clones contained PCR-induced mutations. We therefore cloned by ligation in bacteria the wild-type cyclin B1 cDNA into the pMET25-URA vector and transformed the YPH1015 strain with the recombinant vector. Transformation generated no colony con®rming that overexpression of wild-type cyclin B1 was toxic in yeast. The benomyl assay detected an alteration of the spindle checkpoint when wild-type cyclin B2 or mutant cyclin B1 was overexpressed in yeast ( Figure 3 ).
Cyclins B1 and B2 are overexpressed in human cancers
We investigated the deregulation of human B-type cyclins in a series of 38 primary colorectal cancers. Immunohistochemical staining detected a high level of cyclin B1 expression (percentage of labeled cells over 14%) in ®ve tumors (13%). In these ®ve tumors with a high labeling index, measurement of gene expression by multiplex real-time RT ± PCR (Table 1) detected no overexpression of cyclin B1 mRNA and sequencing of cDNA revealed no mutation within the coding region. Despite the use of several anti-cyclin B2 antibodies, we were unable to detect by immunohistochemistry the expression of cyclin B2 in normal or tumoral colorectal tissues. We therefore analysed directly cyclin B2 mRNA expression using multiplex real-time quantitative RT ± PCR (Table 1) in the 38 colorectal tumors. Five other tumors (13%) exhibited a 2 ± 10-fold increase of cyclin B2 mRNA expression, in comparison to normal colorectal mucosa (Table 2 ). Gene dosage, using quantitative PCR ( Table 1) , showed that overexpression of cyclin B2 was not related to gene ampli®cation.
Discussion
This study shows that a deregulated expression of Clb5 in Saccharomyces cerevisiae alters chromosomal segregation, which can be explained by the role of Clb5 in mitosis: Clb5 is one of the six B-type cyclins (Clb 1 ± 6) in Saccharomyces cerevisiae which activate Cdc28/ CDK1 during progression through S phase and G2/ M transition. Clb5 has been shown to be essential for a proper preanaphase spindle positioning (Segal et al., 1998) . Clb5 is degraded just before the metaphase to anaphase transition by APC Cdc20 and its degradation is required for the mitosis exit (Shirayama et al., 1999) . Only ®ve B-type cyclins have been identi®ed in Xenopus laevis (Minshull et al., 1989) and two from mammalian cells (Pines and Hunter, 1989; Jackman et al., 1995; Brandeis et al., 1998) . Nevertheless, in vertebrate cells, cyclins B1 and B2, which both associate with cdc2/ CDK1, and whose levels rise during G2 and peak in mitosis, have probably distinct roles: in interphase, cyclin B1 is localized mostly to microtubules whereas cyclin B2 is found in the Golgi apparatus (Jackman et al., 1995) ; cyclin B1/CDK1 complex controls chromosome condensation, reorganization of microtubules, destruction of the nuclear membrane, Golgi apparatus fragmentation whereas cyclin B2/CDK1 seems to be only involved in the disassembly of the Golgi apparatus (Draviam et al., 2001) ; cyclin B1 degradation precedes that of cyclin B2 during metaphase/anaphase transition (Minshull et al., 1990; Ohsumi et al., 1994; Brandeis et al., 1998) ; in contrast to cyclin B1, cyclin B2 does not translocate from the cytoplasm to the nucleus at the beginning of prophase (Jackman et al., 1995) ; cyclin B1 is an essential gene since its deletion in mice results in embryonic lethality whereas cyclin B2 7/7 mice develop normally (Brandeis et al., 1998) . Cyclin B2, but not cyclin B1, was recently shown to be essential for a proper bipolar spindle formation in frog (Kotani et al., 2001) , which is reminiscent of the biological role of Clb5 in yeast (Segal et al., 1998 ). The present study shows that overexpression of human cyclin B2, like overexpression of Clb5, alters the spindle checkpoint and chromosome segregation. The eect of cyclin B1 on chromosome segregation was not so clear since the toxicity of wild-type human cyclin B1 precluded its functional analysis in the sectoring assay. Nevertheless, analysis of arti®cial mutant cyclin B1 cDNA (Figures 1 and 2) suggests that deregulation of cyclin B1 could interfere with chromosomal segregation. Interestingly, Yin et al. (2001) recently reported that stable constitutive expression of human cyclin B1 in cell lines treated by nocodazole was able to induce Plates were incubated at 308C for 3 days. Appearance of red sectors within white colonies indicates the loss of the non essential arti®cial chromosomal fragment and therefore chromosome missegregation. The dierence in the size of the colonies containing the pMET-URA3 vector and the colonies containing pMET-Clb5 or pMET-cyclin B2 is due to a dierence in the colonies density on the plates and has therefore no biological signi®cance tetraploidy. The eect of human cyclins B1 and B2 overexpression on chromosomal segregation is reminiscent of that of cyclin E deregulation. Overexpression of cyclin E, which regulates G1/S transition, has been shown to induce CIN in mammalian cells (Spruck et al., 1999) , probably through an impairment of S phase progression. In contrast, the CIN induced by cyclins B overexpression probably results, as shown by the study, from a defect in the spindle checkpoint.
Numerous studies, based on by immunochemistry or Western blot analysis, have previously reported the accumulation of cyclin B1 in malignant tumors such as colorectal and lung cancers (Wang et al., 1997; Soria et al., 2000) but the molecular mechanism underlying this deregulation have not been characterized. Our results show that accumulation of the cyclin B1 protein can be detected in the absence of mRNA overexpression or point mutations suggesting a post-translational deregulation. Since yeast B-type cyclins are physiologically degraded by the APC complex, it is tempting to speculate that accumulation of cyclin B1 might re¯ect a defect in the APC-mediated proteolysis. In contrast, we documented in a subset of malignant tumors a cyclin B2 mRNA overexpression which was not due to gene ampli®cation. Alteration of the TP53 pathway could be one of the mechanisms resulting in the deregulation of cyclin B2 mRNA expression since the down-regulation of the transcription of cyclins B, which normally occur after DNA damage, requires a functional TP53 (Manni et al., 2001) .
In conclusion, these results suggest that a deregulation of human cyclins B by dierent mechanisms could contribute, through an alteration of the spindle checkpoint, to the chromosomal instability of cancerous cells. Figure 3 Benomyl sensitivity of strains overexpressing B-type cyclins. Serial dilutions of the yeast strain YPH1015, containing either the pMET-URA3 vector, pMET-Clb5, pMET-cyclin B1 (containing the Ser342Pro, Asp357Ile, Leu377Pro mutations), or pMET-cyclin B2 plasmid, were spotted onto SD-methionine-uracile plates containing 15 mg/ml of benomyl. A bub1D yeast strain was used as a positive control. Plates were incubated for 4 days at 258C
Materials and methods
Yeast strains and media
The yeast strain used for the sectoring colony assay was YPH1015 Mata ura3-52 lys2-801 ade2-101 his3-D200 trp1-D63 leu2-D1 CFIII (CEN3L.YPH983) HIS3 SUP11 (Connelly and Hieter, 1996) . The yeast strain deleted for BUB1 and used as positive control for the benomyl assay was YMM36 Mata ura3-52 lys2-801 ade2-101 his3-D200 trp1-D63 leu2-D1 CFIII URA3 SUP11 bub1-D1::LEU2. For the sectoring assay, YPH1015 was plated as single colonies on solid media containing a limiting amount of adenine (6 mg/ml). Red pigment was allowed to develop at 48C before scoring the sectoring phenotype. For methionine promoter induction, cells were plated on minimal media without methionine. To study spindle checkpoint status, benomyl was added at 15 mg/ml. Yeast transformation was performed according to the method described by Ito et al. (1983) .
Library screening
The 2 mm yeast genomic library used for the sectoring phenotype screening was previously described (Connelly and Hieter, 1996) . Approximately 1610 5 independent transformants were screened.
Plasmids
To construct the 2 mm pMET25-URA3 vector, a SacI ± BamHI restriction fragment from the pMet424 plasmid (Mumberg et al., 1994) , containing the MET25 promoter, was subcloned into the 2 mm/URA3 pKK244 vector (constructed by K Kitigawa). To generate pMET-Clb5, pMET-cyclin B1, or pMET-cyclin B2, the pMET25-URA3 plasmid was linearized by EcoRI and XhoI, and cotransformed with PCR-ampli®ed ORFs with primers containing additional 35 bp sequences corresponding to the 5' and 3' end of the vector. The resulting contructions were rescued from yeast sectoring colonies.
Fluorescent activated cell sorting (FACS) analysis
FACS analysis was performed as previously described (Hyland et al., 1999) .
Tumor samples
Samples were collected from colorectal tumors after surgical removal. For RNA analysis, samples were directly placed in Figure 4 Protein sequence alignments of Saccharomyces cerevisiae Clb5, and human cyclin B1 or human cyclin B2. Black boxes show amino-acid identities and shaded boxes the conservative changes. Clb5, human cyclin B1 and human cyclin B2 GenBank accession numbers are, respectively, M91209, BC006510 and AB020981 400 ml of RNA extraction buer (Pharmacia) in order to prevent RNA degradation and stored at 7808C until analysed. mRNA was extracted using the Quickprep Micro mRNA puri®cation kit (Pharmacia) and was resuspended in 200 ml water. Random hexamer-primed cDNAs were synthesized from 20 ml mRNA in a ®nal volume of 33 ml using the First-strand cDNA synthesis kit (Pharmacia). DNA was extracted from paran-embedded 9 mm-thick tissue sections using the Dexpat kit (Takara) according to the protocol supplied, puri®ed using phenol/chroloroform, and resuspended in 100 ml water.
Real-time quantitative PCR
Real-time quantitative PCR was performed in the ABI Prism 7700 Sequence Detection System (PE Applied Biosystems, Perkin Elmer). Primers and probes (Table 2) were chosen using the Primer Express software program (PE Applied Biosystems, Perkin Elmer). To quantify cyclin B2 and cyclin B1 mRNA, cyclin B2 or cyclin B1 cDNA was co-ampli®ed with the house-keeping gene porphobilinogen desaminase (PBGD). TaqMan ampli®cation reactions were performed using the components as supplied in the Taqman PCR core reagent kit in a ®nal volume of 25 ml containing 1 ml of RT ± PCR. After 2 min at 508C, then 10 min at 958C, the PCR consisted of 50 cycles of 15 s at 958C, and 1 min at 658C. For each cDNA, the calibration curve (log initial template copy number versus Ct (cycle number at which the¯uorescence crosses a ®xed threshold)) was constructed by analysing dierent quantities of templates (10 2 to 10 6 copies of cDNA).
Cyclin B1 or B2 expression was related to PBGD expression and for each tumor the normalized expression level was compared to that detected in normal colorectal mucosa. For gene dosage assay, exon 3 of cyclin B2 was co-ampli®ed with the albumin gene in a ®nal volume of 25 ml containing 5 ml of genomic DNA extracted from tissue sections. After 2 min at 508C, then 10 min at 958C, the PCR consisted of 50 cycles of 15 s at 958C, and 1 min at 658C. For each gene, the calibration curve was constructed by analysing dierent quantities of genomic DNA (0.39, 1.26, 6.25, 25 and 100 ng). A normalized gene dosage was then determined by dividing the starting copy number of the cyclin B2 gene by that of the co-ampli®ed albumin gene. A ratio between 0.8 and 1.2 was considered as normal. All the measurements were performed in duplicate.
Sequencing analysis
The entire cyclin B1 cDNA (1293 bp) was PCR-ampli®ed in three fragments, using as sense primers and antisense primers, 5'-GCGCTCCGAGTCACCAGGAACTCG-3' (CB1F2) and 5'-ATGCTCTCCGAAGGAAGTGC-3' (CB1R), 5'-TGCCC-CTGCAGAAGAAGACC-3' (CB1F) and CB1R, 5'-CTT-TG GTCTGGGTCGGCCTC-3' (CB1F3) and 5'-ACAC-CTTTGCCACAGCCTTGGC-3' (CB1R3). PCR was performed in a ®nal volume of 50 ml containing 0.5 mM of primers, 200 mM of dNTPs and 1 unit of Taq DNA polymerase (Eurobio). The PCR consisted of 30 cycles of 20 s at 958C, 20 s at 558C, and 1 min at 728C, preceded by 3 min at 948C and followed by 5 min at 728C. PCR products were then puri®ed by electrophoresis on low-melt agarose gel and directly sequenced on both strands using the Big Dye Terminator Kit (PE Applied Biosystems) and an Applied Biosystems model 377 automated sequencer (PE Applied Biosystems).
Immunohistochemical staining
Paran-embedded, 4-mm-thick tissue sections were stained for cyclin B1 using a primary mouse monoclonal antibody (NCL-CYCLIN B1; Novocastra). Sections were then processed using the LSAB+ kit Peroxidase (Dako), according to the manufacturer's instructions, stained with diaminobenzi- Normalized cyclin B2 expression was compared to that measured in normal colorectal mucosa dine and counter-stained with ChemMate Hematoxylin (Dako). The cyclin B1 labeling index was de®ned as the percentage of tumoral cells displaying cytoplasmic or nuclear reactivity estimated from at least 1000 tumor cells for each section. Three representative areas were counted for each tissue section.
